HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
50 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PIN1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
Chromosome 19 · 19p13.2
NCBI Gene: 5300Ensembl: ENSG00000127445.15HGNC: HGNC:8988UniProt: Q13526
529PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
RESEARCH IMPACT
Highly StudiedTrending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
negative regulation of cell motilitypositive regulation of protein phosphorylationregulation of cytokinesispeptidyl-prolyl cis-trans isomerase activityAbnormality of the skeletal systemcancerhepatocellular carcinomaneoplasm
✦AI Summary

PIN1 is a peptidylprolyl cis/trans isomerase that catalyzes conformational changes in phosphorylated Ser/Thr-Pro motifs, acting as a molecular switch regulating multiple cellular processes 1. Through this mechanism, PIN1 controls cell cycle progression, protein degradation, and cellular signaling 1. PIN1 regulates RAF1 dephosphorylation after mitogen activation 2, targets PML and BCL6 for degradation 3, and modulates JNK signaling by destabilizing FBXW7 4. Under hypoxia, PIN1 isomerizes phosphorylated PGK1 to promote mitochondrial targeting 5. PIN1 overexpression is prevalent in multiple cancers, correlating with poor prognosis. Cytoplasmic PIN1 elevation occurs progressively from normal nevi to metastatic melanoma, predicting worse survival 6. PIN1 promotes bladder cancer through SREBP2-mediated cholesterol biosynthesis 7 and maintains glioblastoma telomeres and NF-κB signaling 8. Conversely, PIN1 dysfunction contributes to Alzheimer's disease pathogenesis; reduced PIN1 activity is observed in mild cognitive impairment and AD brains with oxidative modification 910. Additionally, PIN1 downregulation associates with vascular smooth muscle cell senescence in atherosclerosis 11. PIN1 genetic polymorphisms influence cancer susceptibility, with protective effects in breast and lung cancers but increased risk for nasopharyngeal carcinoma 12.

Sources cited
1
PIN1 is a peptidylprolyl cis/trans isomerase that catalyzes conformational changes in phosphorylated Ser/Thr-Pro motifs, acting as a molecular switch regulating multiple cellular processes .
PMID: 21497122
2
PIN1 regulates RAF1 dephosphorylation after mitogen activation , targets PML and BCL6 for degradation , and modulates JNK signaling by destabilizing FBXW7 .
PMID: 15664191
3
PIN1 regulates RAF1 dephosphorylation after mitogen activation , targets PML and BCL6 for degradation , and modulates JNK signaling by destabilizing FBXW7 .
PMID: 17828269
4
PIN1 regulates RAF1 dephosphorylation after mitogen activation , targets PML and BCL6 for degradation , and modulates JNK signaling by destabilizing FBXW7 .
PMID: 22608923
5
Under hypoxia, PIN1 isomerizes phosphorylated PGK1 to promote mitochondrial targeting .
PMID: 26942675
6
Cytoplasmic PIN1 elevation occurs progressively from normal nevi to metastatic melanoma, predicting worse survival .
PMID: 30442923
7
PIN1 promotes bladder cancer through SREBP2-mediated cholesterol biosynthesis and maintains glioblastoma telomeres and NF-κB signaling .
PMID: 39808064
8
PIN1 promotes bladder cancer through SREBP2-mediated cholesterol biosynthesis and maintains glioblastoma telomeres and NF-κB signaling .
PMID: 36960859
9
Additionally, PIN1 downregulation associates with vascular smooth muscle cell senescence in atherosclerosis .
PMID: 28986099
10
PIN1 genetic polymorphisms influence cancer susceptibility, with protective effects in breast and lung cancers but increased risk for nasopharyngeal carcinoma .
PMID: 32268654
Disease Associationsⓘ20
Abnormality of the skeletal systemOpen Targets
0.26Weak
cancerOpen Targets
0.12Weak
hepatocellular carcinomaOpen Targets
0.12Weak
neoplasmOpen Targets
0.11Weak
osteoarthritis, hipOpen Targets
0.11Weak
osteoarthritis, kneeOpen Targets
0.11Weak
ArthralgiaOpen Targets
0.11Weak
breast cancerOpen Targets
0.11Weak
Alzheimer diseaseOpen Targets
0.11Weak
triple-negative breast cancerOpen Targets
0.11Weak
gastric cancerOpen Targets
0.10Suggestive
melanomaOpen Targets
0.10Suggestive
ArthropathyOpen Targets
0.09Suggestive
acute lymphoblastic leukemiaOpen Targets
0.09Suggestive
nasopharyngeal carcinomaOpen Targets
0.09Suggestive
pulmonary arterial hypertensionOpen Targets
0.09Suggestive
non-alcoholic fatty liver diseaseOpen Targets
0.09Suggestive
acute myeloid leukemiaOpen Targets
0.09Suggestive
papillary thyroid carcinomaOpen Targets
0.09Suggestive
non-alcoholic steatohepatitisOpen Targets
0.09Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
IRF3Protein interaction97%HIPK2Protein interaction97%TP53Protein interaction95%POLR2AProtein interaction91%SFNProtein interaction91%MYCProtein interaction88%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
63%
Ovary
61%
Liver
61%
Heart
54%
Lung
52%
Gene Interaction Network
Click a node to explore
PIN1IRF3HIPK2TP53POLR2ASFNMYC
PROTEIN STRUCTURE
Preparing viewer…
PDB7AZ2 · 1.08 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.18LoF Tolerant
pLIⓘ
0.02Tolerant
Observed/Expected LoF0.63 [0.35–1.18]
RankingsWhere PIN1 stands among ~20K protein-coding genes
  • #481of 20,598
    Most Researched529 · top 5%
  • #12,312of 17,882
    Most Constrained (LOEUF)1.18
Genes detectedPIN1
Sources retrieved50 papers
Response time—
📄 Sources
50â–¼
1
Pin1 and Alzheimer's disease.
PMID: 36162703
Transl Res · 2023
1.00
2
Prognostic value of peptidyl-prolyl cis-trans isomerase 1 (PIN1) in human malignant tumors.
PMID: 31728832
Clin Transl Oncol · 2020
0.96
3
PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway.
PMID: 39808064
Cancer Discov · 2025
0.90
4
Pin1 and JNK1 cooperatively modulate TAp63γ.
PMID: 33548094
FEBS Open Bio · 2021
0.90
5
Promoter Methylation and Gene Expression of Pin1 Associated with the Risk of Alzheimer's Disease in Southern Chinese.
PMID: 33557736
Curr Alzheimer Res · 2020
0.88